UCB
The RWE Strategy Lead Respiratory role involves leading the development and delivery of global real-world evidence strategies for respiratory assets, translating research questions into evidence plans, and ensuring alignment with clinical, regulatory, and market access needs. This strategic position requires cross-functional leadership, scientific expertise, and operational oversight to support healthcare decision-makers. The role includes mentoring evidence-generation professionals and building relationships with external experts and stakeholders.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
Director, Real-World Evidence (RWE) Research – Oncology
C0003153479P
Associate Director, US HEOR & RWE (Remote-Based)
Eisai
Director, Real-World Evidence (RWE) Research – Oncology
C0003153479P
Senior Director, Respiratory Innovation, VID Global Epidemiology & RWE
GSK plc
Director, Epidemiology & RWE Sciences
Ipsen
International RWE Lead
AbbVie